Literature DB >> 18180202

Cultivation of Plasmodium vivax.

Rachanee Udomsangpetch1, Osamu Kaneko, Kesinee Chotivanich, Jetsumon Sattabongkot.   

Abstract

Establishment of a continuous line of Plasmodium vivax parasite is crucial to understand the parasite's biology; however, this has not yet been achieved. Beginning in the 19th century, there were several efforts to cultivate this malaria parasite but without much success until the late 1980s. In addition, to date, only minor modifications of the methodology have been investigated, which has resulted in extending the cultivation period to around four weeks by supplying reticulocytes obtained from normal blood or rare hemochromatotic blood. However, the use of laboratory-produced erythroblasts to cultivate P. vivax enables maintenance of a continuous line of the parasite stably in the laboratory. Here, we summarize and compare the available methodologies and conditions for the in vitro cultivation of P. vivax.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180202     DOI: 10.1016/j.pt.2007.09.010

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  44 in total

Review 1.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 2.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

Review 3.  Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.

Authors:  Brice Campo; Omar Vandal; David L Wesche; Jeremy N Burrows
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

4.  Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.

Authors:  Francis B Ntumngia; John H Adams
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

Review 5.  Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

Authors:  Karthigayan Gunalan; Amadou Niangaly; Mahamadou A Thera; Ogobara K Doumbo; Louis H Miller
Journal:  Trends Parasitol       Date:  2018-03-09

6.  Optimized in vitro production of Plasmodium vivax ookinetes.

Authors:  Colleen M McClean; Haydee Guerra Alvarado; Victor Neyra; Alejandro Llanos-Cuentas; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

Review 7.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

Review 8.  New medicines to improve control and contribute to the eradication of malaria.

Authors:  Timothy N C Wells; Pedro L Alonso; Winston E Gutteridge
Journal:  Nat Rev Drug Discov       Date:  2009-10-16       Impact factor: 84.694

9.  Anopheles aquasalis Infected by Plasmodium vivax displays unique gene expression profiles when compared to other malaria vectors and plasmodia.

Authors:  Ana C Bahia; Marina S Kubota; Antonio J Tempone; Waleria D Pinheiro; Wanderli P Tadei; Nágila F C Secundino; Yara M Traub-Csekö; Paulo F P Pimenta
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

10.  Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies.

Authors:  Pamela Orjuela-Sánchez; Nadira D Karunaweera; Mônica da Silva-Nunes; Natal S da Silva; Kézia K G Scopel; Raquel M Gonçalves; Chanaki Amaratunga; Juliana M Sá; Duong Socheat; Rick M Fairhust; Sharmini Gunawardena; Thuraisamy Thavakodirasah; Gawrie L N Galapaththy; Rabindra Abeysinghe; Fumihiko Kawamoto; Dyann F Wirth; Marcelo U Ferreira
Journal:  BMC Genet       Date:  2010-07-13       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.